YProTech Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
YProTech Ltd. - overview
Established
2011
Location
-, -, UK
Primary Industry
Biotechnology
About
YProTech Ltd. is a UK-based technology company specializing in innovative software applications and robust hardware systems designed to enhance operational efficiency across various industries. Founded in 2011 and headquartered in the UK, YProTech Ltd. develops advanced technology solutions aimed at enhancing business operations.
The company has participated in six funding deals, with its most recent transaction occurring on November 7, 2018, where it raised GBP 0. 15 million through a VENTURE DEBT round from investor FW Capital. The total amount raised by the company is GBP 0. 267 million.
The CEO, Stuart Brown, has a background that supports the company's strategic vision. YProTech specializes in providing advanced technology solutions tailored for various industries, focusing on innovative software applications and robust hardware systems. Their core product offerings include a suite of integrated software solutions designed to enhance operational efficiency and productivity for businesses in sectors such as manufacturing, logistics, and healthcare. These applications are engineered to address specific challenges such as data management, process automation, and real-time analytics.
YProTech targets a diverse client base that includes small to medium enterprises as well as large corporations looking to leverage technology for competitive advantage. The products are marketed primarily in North America and Europe, where the demand for technological solutions continues to grow. YProTech generates revenue through a combination of direct sales and subscription-based models for its software offerings. The company has established structured partnerships with various organizations in different sectors, allowing it to implement bespoke solutions tailored to individual client needs.
Transactions typically involve a subscription fee for access to their software platforms, which may vary based on the scale and complexity of services required by the client. Additionally, YProTech’s hardware solutions may be sold separately or bundled with software subscriptions, providing a comprehensive technology package to end users. Flagship products contribute significantly to the overall financial performance, ensuring sustainable revenue streams as clients continue to invest in their technological infrastructure. In November 2018, YProTech Ltd.
raised GBP 0. 15 million in venture funding from FW Capital, part of a larger GBP 0. 40 million equity and debt funding. The company plans to utilize this funding to achieve its strategic goals of expanding its service offerings and developing new medicinal chemistry capabilities.
YProTech intends to explore new market opportunities and geographic regions to facilitate business growth.
Current Investors
Acceleris, Catapult Ventures Group, FW Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.yprotech.com
Verticals
Research (Non-Medical)
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.